AbbVie Contract Manufacturing AbbVie Contract Manufacturing

X

CAS 156474-22-5 manufacturers and suppliers on PharmaCompass

PharmaCompass
CAS 156474-22-5
Also known as: 156474-22-5, Threo-n-boc-d-phenylalanine epoxide, 98818-35-0, (2s,3r)-3-(tert-butoxycarbonylamino)-1,2-epoxy-4-phenylbutane, Tert-butyl n-[(1r)-1-[(2s)-oxiran-2-yl]-2-phenylethyl]carbamate, Mfcd08061626
Molecular Formula
C15H21NO3
Molecular Weight
263.33  g/mol
InChI Key
NVPOUMXZERMIJK-CHWSQXEVSA-N

1 2D Structure

CAS 156474-22-5

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
tert-butyl N-[(1R)-1-[(2S)-oxiran-2-yl]-2-phenylethyl]carbamate
2.1.2 InChI
InChI=1S/C15H21NO3/c1-15(2,3)19-14(17)16-12(13-10-18-13)9-11-7-5-4-6-8-11/h4-8,12-13H,9-10H2,1-3H3,(H,16,17)/t12-,13-/m1/s1
2.1.3 InChI Key
NVPOUMXZERMIJK-CHWSQXEVSA-N
2.1.4 Canonical SMILES
CC(C)(C)OC(=O)NC(CC1=CC=CC=C1)C2CO2
2.1.5 Isomeric SMILES
CC(C)(C)OC(=O)N[C@H](CC1=CC=CC=C1)[C@H]2CO2
2.2 Synonyms
2.2.1 Depositor-Supplied Synonyms

1. 156474-22-5

2. Threo-n-boc-d-phenylalanine Epoxide

3. 98818-35-0

4. (2s,3r)-3-(tert-butoxycarbonylamino)-1,2-epoxy-4-phenylbutane

5. Tert-butyl N-[(1r)-1-[(2s)-oxiran-2-yl]-2-phenylethyl]carbamate

6. Mfcd08061626

7. Rel-tert-butyl ((r)-1-((s)-oxiran-2-yl)-2-phenylethyl)carbamate

8. Schembl5865405

9. Zinc4977933

10. Thred-n-boc-d-phenylalanine Epoxide

11. Akos016843910

12. Bs-15259

13. Cs-0154589

14. F20656

15. (2s,3r)-1,2-epoxy-(boc Amino)-4-phenylbutane

16. (2s,3r)-1,2-epoxy-3-(boc-amino)-4-phenylbutane

17. Tert-butyl (r)-1-((s)-oxiran-2-yl)-2-phenylethylcarbamate

18. (2s,3r)-3-[(t-butoxycarbonyl)amino]-4-phenyl-1,2-epoxybutane

19. Rel-tert-butyl((r)-1-((s)-oxiran-2-yl)-2-phenylethyl)carbamate

2.3 Create Date
2006-10-26
3 Chemical and Physical Properties
Molecular Weight 263.33 g/mol
Molecular Formula C15H21NO3
XLogP32.6
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count3
Rotatable Bond Count6
Exact Mass263.15214353 g/mol
Monoisotopic Mass263.15214353 g/mol
Topological Polar Surface Area50.9 Ų
Heavy Atom Count19
Formal Charge0
Complexity305
Isotope Atom Count0
Defined Atom Stereocenter Count2
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1
Flag China
Digital Content Digital Content
URL Supplier Web Content
20859-02-3
Atazanavir
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology t...
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology to realize its commercial production of chiral compounds.As a wholly-owned subsidiary of Enzymaster®, we think globally and devote to supply high quality chemical products, which are sustainable supply, with eco-friendly process and competitive price.Meanwhile, we provide domestic and overseas customers biocatalytic custom synthesis serves.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag China
Digital Content Digital Content
URL Supplier Web Content
162537-11-3
Atazanavir
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology t...
Based on the excellent enzymatic technology platform, Enzymaster Chemical applies innovative technology to realize its commercial production of chiral compounds.As a wholly-owned subsidiary of Enzymaster®, we think globally and devote to supply high quality chemical products, which are sustainable supply, with eco-friendly process and competitive price.Meanwhile, we provide domestic and overseas customers biocatalytic custom synthesis serves.
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY